Verdict Medical Devices

FDA clears Tandem’s Control-IQ+ technology for type 2 diabetes

The US FDA has cleared Tandem Diabetes Care’s Control-IQ+ technology for use in individuals aged 18 and above with type 2 diabetes (T2D). The post FDA clears Tandem’s Control-IQ+ technology for type 2 diabetes appeared first on Medical Device Network.

Feb 26, 2025 - 12:29
 0
FDA clears Tandem’s Control-IQ+ technology for type 2 diabetes
The US FDA has cleared Tandem Diabetes Care’s Control-IQ+ technology for use in individuals aged 18 and above with type 2 diabetes (T2D).

The post FDA clears Tandem’s Control-IQ+ technology for type 2 diabetes appeared first on Medical Device Network.

Read More

Tags:

Previous Article

‘Complete nonsense’ – English whisky fights back against SWA criticism

Next Article

Arranging finance is biggest pain point for UK car buyers

Related Posts

Helius joins BCI landscape with new subsidiary

Helius joins BCI landscape with new subsidiary

Mar 14, 2025  0

Cerus secures CE mark approval for LED-based illumination device

Cerus secures CE mark approval for LED-based illuminati...

Mar 6, 2025  0

Level Zero Health raises $6.9m for hormone tracking biosensor platform

Level Zero Health raises $6.9m for hormone tracking bio...

Feb 19, 2025  0